Trial reportHaematologica2018
Open access · goldAbstract readRandomized Controlled Trial
In one paragraph
Trial report in Haematologica, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 10% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.
- Dawn of Monitoring Regulatory T Cells in (Pre-)clinical Studies: Their Relevance Is Slowly Recognised.Frontiers in medicine · 2020Pooled it
- Tildrakizumab for the prophylaxis of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.Blood advances · 2026Trial
- Trial
- Long-term survival outcomes of allo-HCT in AML with fludarabine/melphalan conditioning and tacrolimus/sirolimus GVHD prophylaxis.Bone marrow transplantation · 2026Article
- Interleukin Networks in GVHD: Mechanistic Crosstalk, Therapeutic Targeting, and Emerging Paradigms.International journal of molecular sciences · 2025Review
- Imiquimod promotes Th1 and Th17 responses via NF-κB-driven IL-12 and IL-6 production in anExperimental and therapeutic medicine · 2025Article
- Trifolirhizin improves the hyperproliferation and excessive inflammatory response in human HaCaT keratinocytes and ameliorates skin lesions in psoriasis-like mouse models.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2025Article
- Optimal GVHD Prophylaxis.Advances in experimental medicine and biology · 2025Review
- Recent advances and research progress regarding monoclonal antibodies for chronic graft-versus-host disease.Heliyon · 2024Review
- Interleukin-17: A Putative Novel Pharmacological Target for Pathological Pain.Current neuropharmacology · 2024Review
- IL-33 acts as a costimulatory signal to generate alloreactive Th1 cells in graft-versus-host disease.The Journal of clinical investigation · 2022Article
- Advances in Intestinal Barrier Preservation and Restoration in the Allogeneic Hematopoietic Cell Transplantation Setting.Journal of clinical medicine · 2021Review
- Current Concepts and Advances in Graft-Versus-Host Disease Immunology.Annual review of immunology · 2021Article
- Translational Clinical Strategies for the Prevention of Gastrointestinal Tract GraftFrontiers in immunology · 2021Review
- Human CD83-targeted chimeric antigen receptor T cells prevent and treat graft-versus-host disease.The Journal of clinical investigation · 2020Article
- Review
- Monogenic Immune Diseases Provide Insights Into the Mechanisms and Treatment of Chronic Graft-Versus-Host Disease.Frontiers in immunology · 2020Review
- IL-Y Aggravates Murine Chronic Graft-Frontiers in immunology · 2020Article
- Post-transplantation Cyclophosphamide: From HLA-Haploidentical to Matched-Related and Matched-Unrelated Donor Blood and Marrow Transplantation.Frontiers in immunology · 2020Review
- MHC Class II Antigen Presentation by the Intestinal Epithelium Initiates Graft-versus-Host Disease and Is Influenced by the Microbiota.Immunity · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors at 1 institution in 1 country.
Joseph PidalaBlood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL, USA joseph.pidala@moffitt.org.
Francisca BeatoBlood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL, USA.
Jongphil KimBiostatistics, Moffitt Cancer Center, Tampa, FL, USA.
Brian BettsBlood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL, USA.
Heather JimBlood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL, USA.
Elizabeth SagatysHematopathology and Laboratory Medicine, Moffitt Cancer Center, Tampa, FL, USA.
John E LevineTisch Cancer Institute, the Icahn School of Medicine at Mt. Sinai, New York, NY, USA.
James L M FerraraTisch Cancer Institute, the Icahn School of Medicine at Mt. Sinai, New York, NY, USA.
Umut OzbekTisch Cancer Institute, the Icahn School of Medicine at Mt. Sinai, New York, NY, USA.
Ernesto AyalaBlood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL, USA.
Marco DavilaBlood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL, USA.
Hugo F FernandezBlood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL, USA.
Teresa FieldBlood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL, USA.
Mohamed A Kharfan-DabajaBlood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL, USA.
Divis KhairaBlood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL, USA.
Farhad KhimaniBlood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL, USA.
Frederick L LockeBlood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL, USA.
Asmita MishraBlood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL, USA.
Michael NiederBlood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL, USA.
Taiga NishihoriBlood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL, USA.
Lia PerezBlood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL, USA.
Marcie RichesBlood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL, USA.
Claudio AnasettiBlood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL, USA.
Moffitt Cancer Center · US
Funding
TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI KENNETH Lynn WRIGHT · 1998 to 2026
$93.5MVanderbilt Clinical Oncology Research Career Development ProgramK12CA090625 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Debra L. Friedman, Paula Jill Hurley · 2001 to 2026
$16.9MBreaking immune tolerance to Survivin in Multiple MyelomaK23CA201594 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI LOCKE, FREDERICK · 2015 to 2019
$821kNCI NIH HHS K12 CA090625NCI NIH HHS K23 CA201594NCI NIH HHS P30 CA076292
Abstract
T-helper 1 and T-helper 17 lymphocytes mediate acute graft-
Indexed as
AdultAgedFemaleGraft vs Host DiseaseHematologic NeoplasmsHematopoietic Stem Cell TransplantationHumansInterleukin-12Interleukin-23 Subunit p19MaleMiddle AgedTh17 CellsTh1 CellsTransplantation, HomologousUstekinumabYoung AdultIL23A protein, humanInterleukin-12Interleukin-23 Subunit p19Ustekinumab
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.